- JP-listed companies
- SUSMED, Inc.
- Balance sheet
SUSMED, Inc. (4263) Balance sheet
Market cap
¥16.6B
P/E ratio
Susmed develops digital therapeutic apps and IT platforms that help pharmaceutical companies and healthcare providers conduct clinical trials and analyze medical data more efficiently.
| 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | |
| Cash and cash equivalents | - | 366 | 1,627 | 4,904 | 5,049 | 4,847 | 4,398 |
| Total cash & short-term investments | - | 366 | 1,627 | 4,904 | 5,049 | 4,847 | 4,398 |
| Total current assets | - | 379 | 1,675 | 4,936 | 5,085 | 4,898 | 4,463 |
| Property, plant and equipment, net | - | - | - | - | - | - | - |
| Total non-current assets | - | 3 | 0 | 8 | 16 | 34 | 40 |
| Total assets | - | 382 | 1,675 | 4,944 | 5,101 | 4,932 | 4,503 |
| Total current liabilities | - | 23 | 96 | 88 | 225 | 321 | 126 |
| Total non-current liabilities | - | 4 | 1 | 6 | 6 | 6 | 6 |
| Total liabilities | - | 26 | 97 | 93 | 230 | 328 | 132 |
| Retained earnings | - | -458 | -278 | -512 | -563 | -920 | -1,218 |
| Stockholders' equity | 452 | 355 | 1,578 | 4,850 | 4,871 | 4,604 | 4,371 |